Abiomed, Inc. (ABMD) CEO Michael Minogue on Q4 2022 Results - Earnings Call Transcript

Abiomed, Inc. (NASDAQ:NASDAQ:ABMD) Q4 2022 Results Conference Call April 28, 2022 08:00 AM ET Company Participants Nicole Nath - Manager, Investor Relations Michael Minogue - President and...

Related Keywords

Germany ,New York ,United States ,Arkansas ,Japan ,Little Rock ,Denmark ,Belgium ,Italy ,France ,French ,Japanese ,German ,Bobby Goins ,Thurston Bauer ,Raymond James ,Chuck Simonton ,Jayson Bedford ,Brandon Vazquez ,Mike Minogue ,Marie Thibault ,Michael Polark ,Christopher Cooley ,Michael Minogue ,Daniel Antalffy ,Imron Zafar ,Matthew Obrien ,Piper Sandler ,Chris Cooley ,Todd Trapp ,Nicole Nath ,Margaret Kaczor ,William Blair ,Danielle Antalffy ,Morgan Stanley ,Company Participants ,Stephens Inc ,Global Annual Company Meeting ,International Site Of Heart ,Deutsche Bank ,Nasdaq ,William Blair Company ,Abiomed ,European Society Of Cardiology ,Wolfe Research ,Abiomed Inc ,Conference Call April ,Chief Executive ,Chief Financial ,Abiomed Fiscal Year ,Quarter Earnings ,Investor Relations ,Chief Executive Officer ,Vice President ,European Society ,Osaka Hospital ,Tamer Attia ,Emory University Hospital ,Impella Connect ,Impella Bridge To Recovery ,Amir Kaki ,Circulation Heart Failure ,Global Annual Company ,Matthewo Brien ,International Site ,New York City ,Cecilia Furlong ,